Veterinary Medicines

Nobilis RT+IBmulti+ND+EDS emulsion for injection for chickens

Authorised
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Eggdrop syndrome-1976 virus, strain BC14, Inactivated
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
  • Avian infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
Download as PDF

Product identification

Medicine name:
Nobilis RT+IBmulti+ND+EDS emulsion for injection for chickens
Nobilis RT+IB Multi+ND+EDS
Active substance:
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Eggdrop syndrome-1976 virus, strain BC14, Inactivated
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
  • Avian infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
Target species:
  • Chicken
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Newcastle disease virus, strain Clone 30, Inactivated
    50.00
    50% Protective Dose
    /
    0.50
    millilitre(s)
  • Eggdrop syndrome-1976 virus, strain BC14, Inactivated
    6.50
    log2 haemagglutination inhibiting unit(s)
    /
    0.50
    millilitre(s)
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
    9.50
    log2 enzyme-linked immunosorbent assay unit(s)
    /
    0.50
    millilitre(s)
  • Avian infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
    4.00
    log2 virus neutralising unit(s)
    /
    0.50
    millilitre(s)
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    5.50
    log2 virus neutralising unit(s)
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA18
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • (ID2) 500 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 500 millilitre(s)
  • (ID1) 250 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 250 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.01030.01.1
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0209/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • France
  • Greece
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 11/02/2022
Updated on: 14/03/2025
Download

Combined File of all Documents

English (PDF)
Published on: 14/03/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."